Research & development > Life sciences

Oceania has the world's highest risk of rheumatic heart disease

28 August, 2017

A newly released study finds that people living in the Oceania region, including Australia, have the highest risk in the world of having and dying from rheumatic heart disease.

Immunotherapy for peanut allergy proves effective four years on

21 August, 2017

A treatment for deadly peanut allergy has been found to show long-lasting effects, providing what is claimed to be the strongest evidence yet that a cure may be possible for peanut allergy.

New methods for analysing gene function

14 August, 2017

Newly developed methods to produce and analyse genetic mosaics are expected to allow researchers to induce multispectral genetic mosaics in vertebrate models such as mice and zebrafish.

New drug holds promise for therapy-resistant breast cancer

11 August, 2017

Scientists have identified a first-in-class molecule that shuts down estrogen-sensitive breast cancer.

Lizard venom could treat blood clots

11 August, 2017

An international research team is studying various types of lizard venom as possible treatments for blood-clotting diseases.

Gut bacteria composition affects nutritional choices

01 August, 2017

Two new studies have revealed that the gut bacteria composition affects nutritional choices as well as reproduction, using common fruit flies as a model system.

Walter and Eliza Hall in $400m royalties deal for cancer drug

28 July, 2017

The Walter and Eliza Hall Institute of Medical Research has made a landmark deal worth up to US$325 million ($408 million) from the partial sale of royalty rights for anticancer treatment venetoclax.

Complex immune system changes observed after traumatic injury

24 July, 2017

Within the first hour after experiencing a traumatic injury, a person's immune system undergoes a series of complex, dynamic changes, reveals a new study.

Tiny implantable 'seeds' of tissue produce fully functional livers

24 July, 2017 by Anne Trafton, MIT News Office 

In an effort to ease the shortage of livers, US researchers have developed a new way to engineer liver tissue by organising tiny subunits that contain three types of cells embedded into a biodegradable tissue scaffold.

Ebola-fighting super cell discovered

18 July, 2017

Australian and American researchers have discovered a super cell that may have the potential to help contain the Ebola virus.

Gut flora an early marker for heart failure?

14 July, 2017

In the gut of patients with heart failure, important groups of bacteria are found less frequently and the gut flora is not as diverse as in healthy individuals.

Mother's epigenetic memory essential for embryo development and survival

14 July, 2017

It has long been debated if epigenetic modifications accumulated throughout the entire life can cross the border of generations and be inherited by children or even grandchildren.

Gonorrhoea resistance on the rise; new drugs needed

07 July, 2017

Each year around 78 million people are infected with gonorrhoea, a common sexually transmitted infection.

Personalised vaccine prompts strong anti-tumour response in patients

06 July, 2017

A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumour cells has been shown to stimulate a potent, safe and highly specific immune anti-tumour response in melanoma patients, reported scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

Australian-Canadian partnership for medical cannabis

04 July, 2017

LeafCann Group, a Melbourne-based medical cannabis producer, has formed a joint venture with Canadian developer of medical cannabis delivery systems and devices Resolve Digital Health.

  • All content Copyright ¬© 2021 Westwick-Farrow Pty Ltd